Expression of the immunoinhibitory ligand PD-L1 was increased after treatment in all three patients, with the highest level of increase observed in non-responder patient 21 whose tumor showed the highest basal level of PD-L1 expression (Fig. 4e, central panel, and Supplementary Fig. 6b). Here, CD274 is linked to neoplasm.